Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131603) titled 'Correlation between Clinical Laboratory Indicators and Prognosis in Colo... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131610) titled 'Baseline Cardiovascular Comorbidities and Clinical Outcomes of Immunothe... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131614) titled 'Therapeutic Effects of Exercise Rehabilitation on Rotator Cuff Injuries'... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131565) titled 'A clinical study evaluating the efficacy and safety of early treatment c... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131568) titled 'Clinical Features of Sigmoid Sinus Origin Tinnitus with Low-Frequency He... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131573) titled 'A Multicenter, Open-Label, Prospective, Parallel-Controlled Study on the... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131577) titled 'Clinical Observation of Short-Term Use of 3% Diquafosol Sodium Eye Drops... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131581) titled 'Exploration of long-term prognostic factors and biomarkers in patients w... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131585) titled 'A study of local pain medicine injection to improve pain control and rec... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131589) titled 'Xeligekimab in the Early Intervention of Psoriasis Vulgaris' on Sept. 4.... Read More